Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Peptides for Weight Loss: Their Role In Metabolic Health

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by

Peptides, short chains of amino acids, play critical roles in several biological processes, including hormone regulation, immune responses, and cell signaling. Peptides have been growing in interest in the weight loss and fitness communities, driven by their potential to influence metabolism, muscle growth, and fat reduction. 

This article explores the role of peptides in weight loss, examining their effectiveness, underlying mechanisms, and associated risks. It provides a comprehensive understanding of their potential benefits and limitations in the context of health and fitness.

[signup]

What Are Peptides?

Peptides play an essential role in cell signaling and regulating several physiological processes. A peptide is a short string of amino acids that act as signaling molecules to influence the body's production and regulation of hormones and neurotransmitters

Proteins are also made of amino acids but are larger in structure and have a broader range of bodily functions. Peptides bind to receptors on the surface of cells to facilitate the secretion and regulation of hormones.

Types of Peptides

Peptides are commonly used to enhance fitness, assist in weight loss, and treat metabolic disorders such as type 2 diabetes and hyperlipidemia

Growth hormone secretagogues (GHS) are a class of peptides responsible for increasing weight loss by stimulating the release of growth hormone. Growth hormone promotes lipolysis, the process of breaking down stored fat into smaller molecules to use as energy, and protein synthesis to assist in fat loss and muscle gain. 

GLP-1 agonists are another class of peptides used for weight loss. They work by lowering serum glucose levels, enhancing insulin secretion, slowing gastric emptying, increasing glucose uptake in the muscles, and increasing satiety.

Peptides in the Body

Therapeutic peptides act as hormones, neurotransmitters, and growth factors to promote muscle growth, fat loss, and energy levels. Peptides function by stimulating hormone receptors, inhibiting enzymes, modulating the immune system, repleting deficient hormones, or exhibiting antimicrobial properties.

Recent scientific advancements have discovered peptides to have a wide range of applications. From weight loss to modulating inflammation, fighting infections, and promoting anti-aging, peptides are versatile therapeutic agents. 

Common Peptides Used for Weight Loss

Here are the most common peptides that are revolutionizing weight loss strategies and offering new hope for achieving sustainable results.

Glucagon-Like Peptide 1 (GLP-1) Agonists 

GLP-1 agonists, such as semaglutide, are commonly prescribed for type 2 diabetes and are most recently being used for weight loss. This peptide mimics the effect of the GLP-1 incretin hormone and increases the sensitivity of the beta cells in the pancreas to glucose. 

GLP-1 agonists reduce glucose levels by increasing insulin secretion upon glucose intake. GLP-1 agonists support weight loss by suppressing appetite and delaying gastric emptying. When combined with exercise, patients have seen increased fat loss and reduced risk of hyperglycemia. 

CJC-1295

CJC-1295 is a synthetically derived peptide that stimulates growth hormone release from the pituitary gland. Growth hormone is vital for growth and development. 

Higher growth hormone levels have been associated with enhanced lean muscle mass and reduced fat tissue. CJC-1295 increases plasma levels of growth hormone, aiding in the breakdown of fat, increasing overall energy, increasing muscle mass, and improving weight loss. 

Sermorelin & Ipamorelin

Sermorelin is a synthetic peptide that increases growth hormone release from the brain's anterior pituitary gland. Growth hormone helps regulate body composition by boosting metabolism, increasing protein synthesis, and reducing fat mass.

Ipamorelin is a synthetic peptide that activates ghrelin receptors and binds to growth hormone receptors. By binding to growth hormone receptors, ipamorelin increases growth hormone release from the pituitary, resulting in appetite regulation, fat reduction, and improved gastric emptying. 

Scientific Evidence on Peptides for Weight Loss

Long-term studies of GLP-1 agonists have shown beneficial results in managing weight and glucose control. Patients who took GLP-1 agonists long-term (1 year) have shown significantly lower hemoglobin A1c (HbA1c) levels and increased weight loss. 

Studies have also shown that GLP-1 agonists improve quality of life and decrease cardiovascular risks such as high blood pressure and weight loss. 

Studies on sermorelin and ipamorelin show benefits for weight loss, improved sleep, energy, and stamina, and improved symptoms related to hypogonadism. By increasing growth hormone, sermorelin has been shown to increase lean body mass, insulin sensitivity, and testosterone levels. 

Research on ipamorelin shows that it increases lean muscle mass by increasing insulin release. Researchers believe the increase in growth hormone and insulin from ipamorelin is responsible for its fat loss benefits. 

Risks and Potential Side Effects

The most common side effects of GLP-1 agonists include: 

  • Nausea
  • Vomiting
  • Diarrhea
  • Dizziness
  • Mild tachycardia
  • Headaches
  • Hypoglycemia

The following are contraindications of using GLP-1 agonists:

  • Pregnancy
  • Inflammatory bowel disease (IBD)
  • Family history of thyroid cancer and multiple endocrine neoplasia

GLP-1 agonists are considered safe and effective, and the FDA has approved them for chronic weight management in adults and adolescents. 

Growth hormone secretagogues such as ipamorelin and sermorelin are also considered safe. The most common side effects are:

  • Irritation
  • Itching
  • Sensitivity
  • Swelling
  • Pain at the injection site

Increasing growth hormone levels may increase appetite initially, elevate blood sugar levels, and cause fluid retention. GH-promoting peptides should not be used in:

  • Pregnancy or breastfeeding
  • Individuals with untreated hypothyroidism

Regulations and Safety Concerns

Patients interested in peptide therapy should receive counseling from a trained doctor on the benefits, risks, and potential side effects. Since many peptides are not FDA-approved, it is vital to obtain the correct dosing regimen and education on administration when undergoing peptide therapy. 

How Peptides Are Used for Weight Loss

Peptides can be administered by injection, nasal spray, or oral capsules. Due to poor oral availability, GLP-1 agonists such as liraglutide and semaglutide are most commonly administered by subcutaneous injection. GLP-1 agonists may be given weekly or twice weekly, depending on the specific peptide. 

Growth hormone secretagogues such as ipamorelin and sermorelin are most commonly given subcutaneously or intravenously. While some peptides are designed for oral delivery, it is most common to receive peptides through an injection due to their easy degradation by the digestive system. 

Complementary Approaches

If you want to lose weight with peptide therapy, it is essential to integrate a balanced approach that includes dietary and lifestyle adjustments. The following are helpful tools to implement during any weight loss protocol:

When to Consult a Healthcare Professional

If you are considering peptide therapy for weight loss, it is advised to seek medical guidance on potential side effects, drug interactions, and management of underlying conditions. Regular follow-up appointments are necessary for management to assess glucose levels, kidney function, and weight. 

Signs of Adverse Reactions

Injectable peptides may have side effects that require medical attention. The most common side effects associated with subcutaneous injection:

  • Pain
  • Redness
  • Bleeding
  • Swelling at the injection site

Very rarely, infections at the injection site may occur. To minimize side effects, consult a healthcare provider on the proper technique for injections. 

[signup]

Key Takeaways

  • Peptide therapy is an emerging therapeutic tool for weight loss due to its ability to balance glucose levels, increase metabolism, and stimulate growth hormone.
  • It is critical to seek medical supervision when starting peptide therapy to ensure adequate dosing, safety, and monitoring of underlying conditions.
  • All weight loss regimens should include healthy diet and lifestyle choices.

Peptides, short chains of amino acids, play important roles in several biological processes, including hormone regulation, immune responses, and cell signaling. Peptides have been growing in interest in the weight loss and fitness communities, driven by their potential to influence metabolism, muscle growth, and fat management. 

This article explores the role of peptides in weight management, examining their potential effectiveness, underlying mechanisms, and associated risks. It provides a comprehensive understanding of their possible benefits and limitations in the context of health and fitness.

[signup]

What Are Peptides?

Peptides play an essential role in cell signaling and regulating several physiological processes. A peptide is a short string of amino acids that act as signaling molecules to influence the body's production and regulation of hormones and neurotransmitters

Proteins are also made of amino acids but are larger in structure and have a broader range of bodily functions. Peptides bind to receptors on the surface of cells to facilitate the secretion and regulation of hormones.

Types of Peptides

Peptides are commonly explored for their potential to enhance fitness, assist in weight management, and support metabolic health. Growth hormone secretagogues (GHS) are a class of peptides that may support weight management by stimulating the release of growth hormone. Growth hormone is involved in lipolysis, the process of breaking down stored fat into smaller molecules to use as energy, and protein synthesis, which may assist in muscle gain. 

GLP-1 agonists are another class of peptides explored for weight management. They may help by supporting healthy glucose levels, enhancing insulin secretion, slowing gastric emptying, increasing glucose uptake in the muscles, and promoting satiety.

Peptides in the Body

Therapeutic peptides can act as hormones, neurotransmitters, and growth factors to support muscle growth, fat management, and energy levels. Peptides function by stimulating hormone receptors, inhibiting enzymes, modulating the immune system, supporting hormone balance, or exhibiting antimicrobial properties.

Recent scientific advancements have discovered peptides to have a wide range of applications. From weight management to modulating inflammation, supporting the body's defense against infections, and promoting healthy aging, peptides are versatile agents. 

Common Peptides Used for Weight Management

Here are some peptides that are being explored for their potential to support weight management strategies and offer new hope for achieving sustainable results.

Glucagon-Like Peptide 1 (GLP-1) Agonists 

GLP-1 agonists, such as semaglutide, are commonly prescribed for type 2 diabetes and are being explored for weight management. This peptide mimics the effect of the GLP-1 incretin hormone and increases the sensitivity of the beta cells in the pancreas to glucose. 

GLP-1 agonists may support healthy glucose levels by increasing insulin secretion upon glucose intake. They may also support weight management by promoting satiety and delaying gastric emptying. When combined with exercise, individuals have reported increased fat management and reduced risk of hyperglycemia. 

CJC-1295

CJC-1295 is a synthetically derived peptide that stimulates growth hormone release from the pituitary gland. Growth hormone is vital for growth and development. 

Higher growth hormone levels have been associated with enhanced lean muscle mass and reduced fat tissue. CJC-1295 may support the breakdown of fat, increase overall energy, support muscle mass, and aid in weight management. 

Sermorelin & Ipamorelin

Sermorelin is a synthetic peptide that may increase growth hormone release from the brain's anterior pituitary gland. Growth hormone helps regulate body composition by supporting metabolism, protein synthesis, and fat management.

Ipamorelin is a synthetic peptide that activates ghrelin receptors and binds to growth hormone receptors. By binding to growth hormone receptors, ipamorelin may support growth hormone release from the pituitary, potentially aiding in appetite regulation, fat management, and gastric emptying. 

Scientific Evidence on Peptides for Weight Management

Long-term studies of GLP-1 agonists have shown beneficial results in managing weight and glucose control. Patients who took GLP-1 agonists long-term (1 year) have shown significantly lower hemoglobin A1c (HbA1c) levels and increased weight management. 

Studies have also shown that GLP-1 agonists may improve quality of life and decrease cardiovascular risks such as high blood pressure and weight management. 

Studies on sermorelin and ipamorelin suggest potential benefits for weight management, improved sleep, energy, and stamina, and improved symptoms related to hypogonadism. By potentially increasing growth hormone, sermorelin has been shown to support lean body mass, insulin sensitivity, and testosterone levels. 

Research on ipamorelin suggests that it may support lean muscle mass by increasing insulin release. Researchers believe the increase in growth hormone and insulin from ipamorelin may contribute to its fat management benefits. 

Risks and Potential Side Effects

The most common side effects of GLP-1 agonists include: 

  • Nausea
  • Vomiting
  • Diarrhea
  • Dizziness
  • Mild tachycardia
  • Headaches
  • Hypoglycemia

The following are contraindications of using GLP-1 agonists:

  • Pregnancy
  • Inflammatory bowel disease (IBD)
  • Family history of thyroid cancer and multiple endocrine neoplasia

GLP-1 agonists are considered safe and effective, and the FDA has approved them for chronic weight management in adults and adolescents. 

Growth hormone secretagogues such as ipamorelin and sermorelin are also considered safe. The most common side effects are:

  • Irritation
  • Itching
  • Sensitivity
  • Swelling
  • Pain at the injection site

Increasing growth hormone levels may initially increase appetite, elevate blood sugar levels, and cause fluid retention. GH-promoting peptides should not be used in:

  • Pregnancy or breastfeeding
  • Individuals with untreated hypothyroidism

Regulations and Safety Concerns

Patients interested in peptide therapy should receive counseling from a trained doctor on the potential benefits, risks, and side effects. Since many peptides are not FDA-approved, it is vital to obtain the correct dosing regimen and education on administration when undergoing peptide therapy. 

How Peptides Are Used for Weight Management

Peptides can be administered by injection, nasal spray, or oral capsules. Due to poor oral availability, GLP-1 agonists such as liraglutide and semaglutide are most commonly administered by subcutaneous injection. GLP-1 agonists may be given weekly or twice weekly, depending on the specific peptide. 

Growth hormone secretagogues such as ipamorelin and sermorelin are most commonly given subcutaneously or intravenously. While some peptides are designed for oral delivery, it is most common to receive peptides through an injection due to their easy degradation by the digestive system. 

Complementary Approaches

If you want to manage weight with peptide therapy, it is essential to integrate a balanced approach that includes dietary and lifestyle adjustments. The following are helpful tools to consider during any weight management protocol:

When to Consult a Healthcare Professional

If you are considering peptide therapy for weight management, it is advised to seek medical guidance on potential side effects, drug interactions, and management of underlying conditions. Regular follow-up appointments are necessary for management to assess glucose levels, kidney function, and weight. 

Signs of Adverse Reactions

Injectable peptides may have side effects that require medical attention. The most common side effects associated with subcutaneous injection:

  • Pain
  • Redness
  • Bleeding
  • Swelling at the injection site

Very rarely, infections at the injection site may occur. To minimize side effects, consult a healthcare provider on the proper technique for injections. 

[signup]

Key Takeaways

  • Peptide therapy is an emerging tool for weight management due to its potential to support glucose levels, metabolism, and growth hormone stimulation.
  • It is critical to seek medical supervision when starting peptide therapy to ensure adequate dosing, safety, and monitoring of underlying conditions.
  • All weight management regimens should include healthy diet and lifestyle choices.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!
  1. Adeghate, E., & Ponery, A. S. (2004). Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats. Neuro Endocrinology Letters, 25(6), 403–406. https://pubmed.ncbi.nlm.nih.gov/15665799/
  2. Christie, J. (2023, January 6). A functional medicine approach to obesity and weight management. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-obesity
  3. Cloyd, J. (2023, December 27). Hormone Testing 101: How to Test and Interpret Your Results. Rupa Health. https://www.rupahealth.com/post/hormone-testing-101-how-to-test-and-interpret-your-results
  4. Cloyd, J. (2024a, February 27). Exploring Neurotransmitter Testing: A Functional Medicine Perspective on Mental Health. Rupa Health. https://www.rupahealth.com/post/exploring-neurotransmitter-testing-a-functional-medicine-perspective-on-mental-health
  5. Cloyd, J. (2024b, March 1). What is Hyperlipidemia? Symptoms, Testing, and Treatments. Rupa Health. https://www.rupahealth.com/post/what-is-hyperlipidemia-symptoms-testing-and-treatments
  6. Cloyd, J. (2024c, March 7). The Best Supplements for Sustained Energy Boosts. Rupa Health. https://www.rupahealth.com/post/the-best-supplements-for-sustained-energy-boosts
  7. Cloyd, K. (2023, September 7). Unlocking Hormonal Health: A Comprehensive Guide to Understanding and Choosing the Right Hormonal Testing for Your Patients. Rupa Health. https://www.rupahealth.com/post/unlocking-hormonal-health-a-comprehensive-guide-to-understanding-and-choosing-the-right-hormonal-testing-for-your-patients
  8. Colin, I. M., & Gérard, A.-C. (2022). Once-weekly 2.4 mg Semaglutide for Weight Management in Obesity: A Game Changer? Endocrinology, 18(1), 35. https://doi.org/10.17925/ee.2022.18.1.35
  9. Collins, L., & Costello, R. A. (2023). Glucagon-like peptide-1 receptor agonists. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK551568/
  10. Courtney, H., Nayar, R., Rajeswaran, C., & Jandhyala, R. (2017). Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 10, 79–87. https://doi.org/10.2147/dmso.s126763
  11. Diorio, B. (2023, January 17). Why Most Functional Medicine Practitioners Say No To Alcohol. Rupa Health. https://www.rupahealth.com/post/why-most-functional-medicine-practitioners-say-no-to-alcohol
  12. Easthope, A. (2022, April 26). 11 Common Causes Of Low Male Testosterone (And How To Fix Them). Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-low-male-testosterone-hypogonadism
  13. FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight. (2024, March 8). FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or
  14. Forbes, J., & Krishnamurthy, K. (2020). Biochemistry, Peptide. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK562260/
  15. Glucose. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/glucose
  16. Growth Hormone. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/growth-hormone
  17. Insulin. (n.d.). Rupa Health. https://www.rupahealth.com/biomarkers/insulin
  18. Ionescu, M., & Frohman, L. A. (2006). Pulsatile Secretion of Growth Hormone (GH) Persists during Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog. The Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797. https://doi.org/10.1210/jc.2006-1702
  19. Ishida, J., Saitoh, M., Ebner, N., Springer, J., Anker, S. D., & Haehling, S. (2020). Growth hormone secretagogues: history, mechanism of action, and clinical development. JCSM Rapid Communications, 3(1), 25–37. https://doi.org/10.1002/rco2.9
  20. Koliaki, C., Spinos, T., Spinou, Μ., Brinia, Μ.-E., Mitsopoulou, D., & Katsilambros, N. (2018). Defining the Optimal Dietary Approach for Safe, Effective and Sustainable Weight Loss in Overweight and Obese Adults. Healthcare, 6(3), 73. https://doi.org/10.3390/healthcare6030073
  21. Lee, J. H., & Cho, J. (2022). Sleep and Obesity. Sleep Medicine Clinics, 17(1), 111–116. https://doi.org/10.1016/j.jsmc.2021.10.009
  22. Lee, S. (2024, February 16). Peptides: What They Are, And Why The FDA Is Paying Attention. Rupa Health. https://www.rupahealth.com/post/peptides-what-they-are-and-why-the-fda-is-paying-attention
  23. Magda Sara Wojtara, Mazumder, A., Syeda, Y., & Nikodem Mozgała. (2023). Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management. Advances in Medicine, 2023, 1–7. https://doi.org/10.1155/2023/9946924
  24. Magerman, R. (2024, February 14). The Top 4 Herbal Antimicrobials for Your Functional Medicine Toolkit. Rupa Health. https://www.rupahealth.com/post/the-top-4-herbal-antimicrobials-for-your-functional-medicine-toolkit
  25. Maholy, N. (2023a, March 9). Integrative Medicine Protocol For Reversing Type 2 Diabetes. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-protocol-for-reversing-type-2-diabetes
  26. Maholy, N. (2023b, May 10). A Functional Medicine Immune Support Protocol. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-immune-support-protocol
  27. Mayo Clinic (Ed.). (n.d.). Sermorelin (Injection Route) Side Effects - Mayo Clinic. Www.mayoclinic.org. Retrieved June 3, 2024, from https://www.mayoclinic.org/drugs-supplements/sermorelin-injection-route/side-effects/drg-20065923?p=1#:~:text=Sermorelin%20is%20a%20synthetic%20(man
  28. NHS. (2023, February 15). Causes - obesity. NHS; NHS. https://www.nhs.uk/conditions/obesity/causes/
  29. Orbeta, R. (2022, June 6). 10 Type 2 Diabetes Risk Factors You May Not Know About. Rupa Health. https://www.rupahealth.com/post/what-causes-type-2-diabetes
  30. Perera, H. (2024, March 11). Anterior Pituitary (Its Hormones, Functions, & More). Rupa Health. https://www.rupahealth.com/post/hormones-by-anterior-pituitary
  31. Preston, J. (2023, September 22). How is Chronic Inflammation Linked to Weight Gain? Rupa Health. https://www.rupahealth.com/post/how-is-chronic-inflammation-linked-to-weight-gain
  32. Shaji, J., & Patole, V. (2008). Protein and peptide drug delivery: Oral approaches. Indian Journal of Pharmaceutical Sciences, 70(3), 269. https://doi.org/10.4103/0250-474x.42967
  33. Sigalos, J. T., & Pastuszak, A. W. (2018). The Safety and Efficacy of Growth Hormone Secretagogues. Sexual Medicine Reviews, 6(1), 45–53. https://doi.org/10.1016/j.sxmr.2017.02.004
  34. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology, 9(S2), S149-S14S159. https://doi.org/10.21037/tau.2019.11.30
  35. Stanford, J. (2024a, February 19). The Hidden Perils of Refined Carbohydrates: What Every Healthcare Professional Needs to Know. Rupa Health. https://www.rupahealth.com/post/the-hidden-perils-of-refined-carbohydrates-what-every-healthcare-professional-needs-to-know
  36. Stanford, J. (2024b, May 23). Growth Hormone: The Key to Development, Health, and Longevity. Rupa Health. https://www.rupahealth.com/post/growth-hormone
  37. Sweetnich, J. (2023, May 24). Overview of The Pancreas: Top Conditions, Specialty Testing, and Integrative Medicine Treatment Options. Rupa Health. https://www.rupahealth.com/post/pancrease-101-with-testing-top-conditions
  38. Teeter, L. A. (2023, April 11). How Functional Nutrition Can Support Healthy Aging. Rupa Health. https://www.rupahealth.com/post/how-functional-nutrition-can-support-healthy-aging
  39. Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J.-P., & Frohman, L. A. (2006). Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults. Zenodo. https://doi.org/10.1210/jc.2005-1536
  40. Usach, I., Martinez, R., Festini, T., & Peris, J.-E. (2019). Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. Advances in Therapy, 36(11), 2986–2996. https://doi.org/10.1007/s12325-019-01101-6
  41. Weinberg, J. (2023, December 19). The Science of Sleep: Functional Medicine for Restorative Sleep. Rupa Health. https://www.rupahealth.com/post/the-science-of-sleep-functional-medicine-for-restorative-sleep
  42. Weinberg, J. L. (2022, September 7). An Integrative Medicine Approach to Hypothyroidism. Rupa Health. https://www.rupahealth.com/post/understanding-hypothyroidism-and-how-to-treat-it-naturally
  43. Wu, L. (2019). Chapter 1. Regulatory Considerations for Peptide Therapeutics. Peptide Therapeutics, 1–30. https://doi.org/10.1039/9781788016445-00001
  44. Yoshimura, H. (2023a, November 7). The remarkable power of exercise on our health: A comprehensive overview. Rupa Health. https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview
  45. Yoshimura, H. (2023b, November 13). Sweat It Out: The Powerful Connection Between Exercise and Insulin Sensitivity. Rupa Health. https://www.rupahealth.com/post/sweat-it-out-the-powerful-connection-between-exercise-and-insulin-sensitivity
  46. Yoshimura, H. (2023c, November 21). The Sugary Scale: How Sweet Treats Tip the Balance on Weight. Rupa Health. https://www.rupahealth.com/post/the-sugary-scale-how-sweet-treats-tip-the-balance-on-weight
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
National Library of Medicine
Government Authority
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
National Cancer Institute
Government Authority
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source